DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

89.45 1.51 (1.72%)

REAL-TIME: Last trade at

Extended Hours: $89.45 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

BMRN $89.45 1.72%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $88.69
Previous Close $87.94
Daily Range $87.34 - $91.40
52-Week Range $55.04 - $91.40
Market Cap $13.2B
P/E Ratio -99.93
Dividend (Yield) $0.00 (0.0%)
Volume 1,957,827
Average Daily Volume 1,181,342
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary Rss Feed

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Rolling With Biotech's Regulatory Punches: Chen Lin

New Lifetime High Today: Biomarin Pharmaceutical (BMRN)

RBC Has Three Top Biotech Picks for Year End and 2015

Benzinga's M&A Chatter for Monday November 24, 2014

Closing Update: Stocks Extend Winning Streak to Third Day

S&P 500 Little Changed Amid Uncertainty Over U.S. Economic Growth

Barbarian At The Gate: Biomarin Pharmaceutical (BMRN)

Health Care Sector Update for 11/24/2014: TTPH,ATLN,RHHBY,RNA,BMRN,TTHI,TTH.TO

Mid-Afternoon Market Update: Trina Solar Drops After Quarterly Results; Tetraphase Pharmaceuticals S

Mid-Afternoon Market Update: Trina Solar Drops After Quarterly Results; Tetraphase Pharmaceuticals Shares Spike Higher

See More BMRN News...

BMRN's Top Competitors

BMRN $89.45 (1.72%)
Current stock: BMRN
AMGN $162.24 (-1.18%)
Current stock: AMGN
GILD $101.11 (0.51%)
Current stock: GILD
BIIB $305.40 (-0.44%)
Current stock: BIIB